Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.7210
-0.0342 (-4.53%)
At close: Mar 28, 2025, 4:00 PM
0.7279
+0.0069 (0.95%)
Pre-market: Mar 31, 2025, 8:39 AM EDT

Seres Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
0.14-113.72-250.16-65.58-89.13
Upgrade
Depreciation & Amortization
14.6715.146.635.956.58
Upgrade
Other Amortization
1.411.140.712.530.55
Upgrade
Loss (Gain) From Sale of Assets
-146.39----
Upgrade
Asset Writedown & Restructuring Costs
3.27----
Upgrade
Loss (Gain) From Sale of Investments
--0.240.690.50.45
Upgrade
Stock-Based Compensation
20.9734.125.4820.228.82
Upgrade
Other Operating Activities
22.845.26.231.542.32
Upgrade
Change in Accounts Receivable
6.61-8.67-9.39-7.6
Upgrade
Change in Inventory
-33.8-29.65---
Upgrade
Change in Accounts Payable
-2.94-11.582.29.36-1.16
Upgrade
Change in Unearned Revenue
-4.126.41-7.13-4.36-11.57
Upgrade
Change in Other Net Operating Assets
-31.26-15.48-13.4727.14-2.87
Upgrade
Operating Cash Flow
-148.61-117.35-228.826.69-93.61
Upgrade
Capital Expenditures
-0.38-7.98-9.82-9.57-0.59
Upgrade
Divestitures
141.27----
Upgrade
Investment in Securities
-18.5692.2573.65-158.3
Upgrade
Other Investing Activities
1.4----
Upgrade
Investing Cash Flow
142.2910.5882.4364.09-158.89
Upgrade
Long-Term Debt Issued
-103.3827.61--
Upgrade
Long-Term Debt Repaid
-127.91-52.86-1.91-0.95-
Upgrade
Net Debt Issued (Repaid)
-127.9150.5225.7-0.95-
Upgrade
Issuance of Common Stock
37.5321.19103.92.13303.42
Upgrade
Financing Cash Flow
-90.3771.71129.61.18303.42
Upgrade
Foreign Exchange Rate Adjustments
-00-0-0-
Upgrade
Miscellaneous Cash Flow Adjustments
--0--
Upgrade
Net Cash Flow
-96.69-35.07-16.7971.9550.92
Upgrade
Free Cash Flow
-148.99-125.33-238.64-2.88-94.2
Upgrade
Free Cash Flow Margin
----1.99%-283.61%
Upgrade
Free Cash Flow Per Share
-0.96-0.98-2.21-0.03-1.18
Upgrade
Cash Interest Paid
10.8612.554.932.452.45
Upgrade
Levered Free Cash Flow
-60.11-103.56-87.8214.04-52.03
Upgrade
Unlevered Free Cash Flow
-61.52-103.16-84.7713.34-50.75
Upgrade
Change in Net Working Capital
20.9622.49-5.39-37.0410.48
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q